Urs Jaisli - Roche Holding Insider

Roche Holding AG -- USA Stock  

USD 27.74  0.005  0.018%

Chief Compliance Officer

We currently do not have informatin regarding Urs Jaisli. This executive tanure with Roche Holding AG is not currenlty determined.
Age: 61        
41 61 688 11 11  http://www.roche.com

Management Efficiency

The company has return on total asset (ROA) of 14.37 % which means that it generated profit of $14.37 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 31.85 % meaning that it generated $31.85 on every $100 dollars invested by stockholders.
The company has accumulated 19.8 B in total debt with debt to equity ratio (D/E) of 65.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Roche Holding AG has Current Ratio of 1.39 which is within standard range for the sector.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Qi LanChina Merchants Bank Co Ltd
2004
Kyoji MurakamiNTT DOCOMO INC
2016
Katsuyuki TakagiNTT DOCOMO INC
2017
Sonia AlemanInterconexin Elctrica S A E S P
2015
Karenann TerrellGlaxoSmithKline plc
2017
Carlos MedinaInterconexin Elctrica S A E S P
N/A
Qi ZhuChina Merchants Bank Co Ltd
2008
Gloria TrujilloInterconexin Elctrica S A E S P
N/A
Antonio AbadinIndustria de Diseo Textil S A
2016
David RedfernGlaxoSmithKline plc
2008
Olga MarinInterconexin Elctrica S A E S P
2014
Liang WangChina Merchants Bank Co Ltd
2016
Ju ZhaoChina Merchants Bank Co Ltd
2014
Victoria WhyteGlaxoSmithKline plc
2011
Qingbin WangChina Merchants Bank Co Ltd
2011
Shiqing XuChina Merchants Bank Co Ltd
N/A
Masahira SakaguchiNTT DOCOMO INC
2014
Jianjun LiuChina Merchants Bank Co Ltd
2013
Tomohisa UenoNTT DOCOMO INC
2015
Kenichi MoriNTT DOCOMO INC
2015
Hiroyasu AsamiNTT DOCOMO INC
2016

Entity Summary

Roche Holding AG diagnostics and pharmaceuticals businesses in Switzerland, Germany, and rest of Europe. The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holding operates under Drug Manufacturers - Major classification in USA and traded on OTC Market. It employs 93734 people.Roche Holding AG (RHHBY) is traded on OTC Market in USA. It is located in Konzern Hauptsitz and employs 93,734 people.

Roche Holding AG Leadership Team

Osamu Nagayama, CEO
Michael Varney, Executive, Ph.D
Silvia Ayyoubi, Executive
Sophie KornowskiBonnet, Executive
Beatrice Mauro, Director
Cristina Wilbur, Executive
Roland Diggelmann, COO
Gottlieb Keller, Executive, Ph.D
Urs Jaisli, Executive
Daniel ODay, COO, MBA
DeAnne Julius, Director
Karl Mahler, Executive
Andre Hoffmann, Chairman, MBA
John Reed, Executive, Ph.D
Claudia Dyckerhoff, Director, Ph.D
Fritz Gerber, Chairman, Ph.D
Stephan Feldhaus, Executive, Ph.D
Julie Brown, Director
Richard Lifton, Director
Paul Bulcke, Director
Christoph Franz, Director
PerOlof Attinger, CEO
Pius Baschera, Director, Ph.D
Peter Voser, Director
Bernard Poussot, Director
John Bell, Director, Ph.D
Andreas Oeri, Director, Ph.D
Alan Hippe, Executive
F Hoffmann, Executive
Severin Schwan, CEO, Ph.D
Anita Hauser, Director

Stock Performance Indicators

Current Sentiment - RHHBY

Roche Holding AG Investor Sentiment
Most of Macroaxis users are at this time bullish on Roche Holding AG. What is your perspective on investing in Roche Holding AG? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Trending Equities

Currently Active Assets on Macroaxis
F   
 NYQ 
Purchased over 200 shares of
a day ago
Traded for 10.96
MSFT   
 NMS 
Purchased over 30 shares of
a day ago
Traded for 96.11
GM   
 NYQ 
Purchased over 70 shares of
a day ago
Traded for 37.77
DD   
 NYQ 
Purchased over 100 shares of
a day ago
Traded for 30.6
CRM   
 NYQ 
Purchased over 20 shares of
a day ago
Traded for 124.06
RKDA   
 NCM 
Purchased over 100 shares of
a day ago
Traded for 23.82
Additionally take a look at Your Equity Center. Please also try World Markets Correlation module to find global opportunities by holding instruments from different markets.